Skip to main content
. 2021 Jun 2;16(6):e0252272. doi: 10.1371/journal.pone.0252272

Table 1. Characteristics of study participants at enrollment.

Atopic Dermatitis N = 11 Control Subjects N = 11 p-value
Age (years)1 20.6 [16.2–26.2] 28.8 [22.6–36.8] 0.15
Gender2 Male 36% 45% 1.00
Female 64% 55%
Ethnicity2 Caucasian 46% 36% 1.00
African American 18% 0%
Asian 36% 46%
Other 0% 18%
Birth history2 Vaginal delivery 73% 91% 0.59
Caesarian delivery 27% 9%
Medical history2 Allergies3 100% 36% 0.0039
Family history2 Allergies3 100% 64% 0.09
SCORAD1 33 [23.8–45.4] 0 [0–0] N/A
AD severity4 Mild 36% N/A <0.01
Moderate 46%
Severe 18%
AD medications2 Emollients 100% 0% <0.01
Topical steroids 91% 0%
Systemics 18% 0%
Skin barrier1 TEWL 11.1 [8.6–14.3] 7.1 [6.0–8.4] 0.0064
pH 4.88 [4.67–5.1] 4.86 [4.6–5.13] 1.00
Presence of dermatitis2 ACV-treated forearm 73% 0% <0.01
Water-treated forearm 73% 0%

1 Geometric mean [95% confidence interval]

2 Percentage of subjects (prevalence)

3 Positive history of allergies included asthma, food, or environmental allergies

4 AD severity was mild (if SCORAD <25), moderate (if SCORAD 25–50), or severe (if SCORAD >50).